Approvals/TGA/BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial

Approved

STANDARD

BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial

Merck Healthcare Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: 7c5ed1531ca945d0
Product Name: BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial
Artg Id: 282729
Artg Name: BAVENCIO avelumab (rch) 200 mg/10 mL concentrated solution for intravenous infusion vial
Sponsor: Merck Healthcare Pty Ltd
Company Detail Path: /organization/merck-healthcare-pty-ltd
Artg Date: 2018-01-03
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/740fd0ffe4957283c633e507012fc32f.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/b87aeab0805a1ad163a892f7c891039f.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

7c5ed1531ca945d0

Type

Standard